NCT04522869View on ClinicalTrials.gov

Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 10, 2019

Primary Completion Date

September 25, 2021

Study Completion Date

October 25, 2021

Conditions

Primary Biliary Cirrhosis

Interventions

BIOLOGICAL

Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation

Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Liver Cirrhosis Due to Biliary Atresia

Trial Locations (2)

10000

Vinmec Research Institute of Stem cell and Gene Technology, Hanoi

100000

Vinmec International Hospital Times City, Hanoi

All Listed Sponsors

collaborator

Number 2 Children's Hospital, Ho Chi Minh City

OTHER

lead

Vinmec Research Institute of Stem Cell and Gene Technology

OTHER

NCT04522869 - Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia | Biotech Hunter | Biotech Hunter